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Autoinhibition plays a significant role in the regula-
tion of many proteins. By analyzing autoinhibited
proteins, we demonstrate that these proteins are en-
riched in intrinsic disorder because of the properties
of their inhibitory modules (IMs). A comparison of
autoinhibited proteins with structured and intrinsi-
cally disordered IMs revealed that in the latter group
(1) multiple phosphorylation sites are highly abun-
dant; (2) splice variants occur in greater number
than in their structured cousins; and (3) activation is
often associated with changes in secondary struc-
ture in the IM. Analyses of families of autoinhibited
proteins revealed that the levels of disorder in IMs
can vary significantly throughout homologous pro-
teins, whereas residues located at the interfaces
between the IMs and inhibited domains are con-
served. Our findings suggest that intrinsically disor-
dered IMs provide advantages over structured ones
that are likely to be exploited in the fine-tuning of
the equilibrium between active and inactive states
of autoinhibited proteins.
INTRODUCTION
Fidelity in cellular signaling isdependent on theprecise regulation
of protein activities. It has become increasingly evident that cis-
acting inhibitory sequence elements play an important role in
the regulation of the activity of many proteins (Pufall and Graves,
2002). The inhibition of the function of a protein domain via
interactions with an inhibitory module (IM) in the same polypep-
tide chain is called autoinhibition. Used in signaling proteins,
autoinhibition can prevent spurious activation and prime the
pathway to respond only to appropriate signals. Attenuation of
DNA-protein or protein-protein interactions is themost frequently
observed class of autoinhibition. For instance, DNA binding of
many transcription factors, including Ets-1 (Lee et al., 2005),
NF-kB (Sto¨ven et al., 2000), p53 (Ko and Prives, 1996), and s70
(Dombroski et al., 1993), is regulated by IMs. Another example
is the binding of WASP to the Arp1/3 complex, which activates
actin polymerization and is dependent on the relief of autoinhibi-
tion (Padrick and Rosen, 2010). IMs are also frequently used to
regulate enzyme activity. Many kinases are autoinhibited by332 Structure 21, 332–341, March 5, 2013 ª2013 Elsevier Ltd All righjuxtamembrane domains or other domains that are part of the
same polypeptide chain (Hubbard, 2004). Autoinhibition can
also impact the cellular localization of a protein as illustrated by
the ezrin-radixin-moesin (ERM) (Pearson et al., 2000) proteins,
whose membrane attachment is regulated by an IM.
In the simplest architecture, the autoinhibited protein consists
of a functional domain (FD) whose activity is regulated by at least
one IM (Figure 1). Inhibition of the activity of the FD can be
achieved via allosteric mechanisms or direct occlusion of the
FD’s active site, that is, its catalytic or binding site. Reversal of
inhibition generally relies on posttranslational modifications
(PTMs), binding to activating partners or the irreversible proteol-
ysis of the IM (Pufall and Graves, 2002). Alternatively, autoinhibi-
tion can also be reinforced via binding to other biomolecules or
PTMs. Hence, the autoinhibited protein exists in at least two
states: an inhibited (inactive) state, in which the IM is bound to
the FD, and an active state, in which FD and IM do not interact.
For some autoinhibited proteins, it has been established that
the active and inhibited states exist in a dynamic equilibrium,
the balance of which can be shifted by the mechanisms that
regulate inhibition (Li et al., 2008).
Transitions between the active and inhibited states are usually
associated with structural changes that require a certain flexi-
bility in the polypeptide segments that tether the IMs to the
FDs (Figure 1). Flexible linkers enable the detachment of the
IMs from the FDs leading to the relief of autoinhibitory interac-
tions. However, structural changes can also occur in the FDs
and the IMs themselves. Particularly for the IMs, a broad spec-
trum of structural changes has been observed (Pufall and
Graves, 2002). In the extreme case, the IM is unstructured in
the active state and only adopts a structure when bound to
and inhibiting the FD. In recent years, there have been an
increasing number of studies that report such intrinsically disor-
dered IMs (Kim et al., 2000; Pufall et al., 2005; Li et al., 2008). This
may not come as a surprise given that intrinsically disordered
segments are very common in eukaryotic proteins (Ward et al.,
2004), particularly those that are involved in signaling and regu-
lation (Iakoucheva et al., 2002; Gsponer et al., 2008). Neverthe-
less, the extent of usage of such intrinsically disordered IMs
and the advantages they confer to the autoinhibitory mechanism
are not fully established.
Here, we demonstrate that autoinhibitory proteins are en-
riched significantly in intrinsic disorder because of the properties
of their IMs. Comparing intrinsically disordered IMs with struc-
tured ones, we reveal that in the former group (1) splicing more
often affects the composition of the IMs, (2) phosphorylation
sites are more frequent, and (3) changes in secondary structurets reserved
Figure 1. Regulation of Autoinhibition
In autoinhibited proteins, an inhibitory module (IM,
blue) modulates/inhibits the activity of a functional
domain (FD, cyan). Equilibrium between active and
inhibited states is regulated, that is, autoinhibition
can be actively relieved (right side) or reinforced
(left side). Reversal of autoinhibition in most
systems relies on posttranslational modifications
(PTMs), such as phosphorylation, binding to an
activating partner, or proteolytic cleavage of the IM
(right side). Reinforcement of autoinhibition has
been shown to be caused by binding of partners or
PTMs (left side). Autoinhibition can be caused by
direct, steric interactions of the IM with the FD but
can also be induced allosterically. This figure was
adapted from Pufall and Graves (2002). See also
Tables S2 and S4 and Figure S2.
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Intrinsic Disorder in Autoinhibitionupon activation, which either allow binding to other proteins or
exposure of phosphorylation sites, are more prevalent. More-
over, analysis of entire protein families that are regulated via
autoinhibition, such as subtilisin proteases, reveals that the
whole structural spectrum is explored for the IMs: in certain
family members the IM is an independently folding unit, whereas
in others it is completely disordered in isolation. We propose that
variations in intrinsic disorder of IMs contribute to the fine-tuning
of the equilibrium between the active and inactive states.
RESULTS AND DISCUSSION
IMs of Autoinhibited Proteins Are Enriched in Intrinsic
Disorder
As a first step to analyze the prevalence of intrinsic disorder in the
IMs of autoinhibited proteins, all proteins listed in a review on
autoinhibition by Pufall and Graves (2002) were considered
(review data set; Table S1 available online). Boundaries of IMs
were taken directly from the original papers in which they were
described. The DISOPRED2 algorithm (Ward et al., 2004) was
then used to predict, based on the sequence, the intrinsic level
of disorder, both within and outside the regions implicated in
autoinhibition. The IMs in this data set are clearly enriched in
intrinsic disorder relative to other regions of the proteins they
occur in (p value 2 3 105; Wilcoxon test) or randomly sampled
subsequences taken from the human proteome (p value 3 3
106; Wilcoxon test) with the same length distribution as the
IMs (Figure 2A). It is important to note that non-IM regions of
autoinhibited proteins are not significantly more disordered
than human proteins in general (p value 0.5; Wilcoxon test) and
that the detected enrichment of disorder in IMs is independent
of the prediction method used (Figure S1A). For many proteins
in this set, the minimal regions necessary for autoinhibition
were determined by generating different protein fragments or
mutants followed by activity assays. In the absence of high-
resolution structures, such approaches may not allow the most
accurate delimitation of IMs.Structure 21, 332–341, March 5, 2013IMs with Known Structure Are
Regularly Intrinsically Disordered
To allow for a more precise definition of
the boundaries of IMs, the Protein DataBank (PDB) and the literature were searched for proteins with
known structures of their autoinhibited state (see the Experi-
mental Procedures). We identified 46 proteins in which residues
outside an independently functioning region (the FD) of the
protein impose an autoinhibited conformation by intramolecular
interactions (structural data set; Table S3). Definitions of the IMs
were taken from the publications in which the structures were
first described, and inhibitory interface residues (IIRs) were
defined as those IM residues that are in direct contact with the
FD. The IMs in the new data set are also significantly enriched
in disorder when compared to the FDs (p value 5 3 105;
Wilcoxon test) or similarly sized peptide segments that were
taken randomly from other proteins in the PDB (p value 3 3
1016; Wilcoxon test, Figure 2B). Importantly, this trend is inde-
pendent of the prediction program used (Figure S1B).
Further support for the enrichment of intrinsic disorder in these
IMs comes from experimental data. For 19 proteins, experi-
mental evidence for the intrinsically disordered nature of the IM
could be found (see the Experimental Procedures). On the other
hand, 11 IMs contain an annotated domain, which are known to
fold independently (Table S3). These findings allowed us to clas-
sify the set of autoinhibited proteins for which the structure is
known into two groups (Figure 2C). The first group contains
only proteins with intrinsically disordered IMs (idIMs; see Figures
3A–3D for illustrative examples). Besides the proteins with
experimental evidence for disorder, this group contains five
additional proteins, which two or more predictors classified as
having intrinsically disordered IMs. The group of structured
IMs (sIMs) harbors the 11 proteins with annotated domains
in their IM (see Figure 3F for an illustrative example) as well as
11 proteins with no significant enrichment for disorder according
to the predictors. The latter group of proteins may contain some
borderline cases, such as the receptor tyrosine kinases Kit
(Mol et al., 2004) (Figure 3E) and EphB2 (Wybenga-Groot et al.,
2001), which are autoinhibited by their juxtamembrane regions
(JMR). Large parts of the juxtamembrane regions are disordered
in the X-ray structures of these and several other members ofª2013 Elsevier Ltd All rights reserved 333
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Figure 2. Intrinsic Disorder in IMs
(A) Box plot of the distribution of disorder in the IM
and non-IM regions in proteins from the review of
Pufall and Graves (2002) (review data set; n = 39).
HP, randomly selected sequences from the human
proteome. **p < 0.001.
(B) Box plot of the distribution of disorder for the
IMs and FDs of autoinhibited proteins with known
structures (structural data set; n = 46). PDB,
randomly selected sequences from the PDB.
(C) Categorization of the structural set (n = 46)
into idIM (green) and sIM (gray).
(D) Box plot of the distribution of SASA buried at
the IM-FD interface for proteins in the idIM and sIM
groups. sP and idP are the SASAs buried by
groups of structures and intrinsically disordered
proteins, respectively, when in complex with
a globular partner (complexes were taken from
Me´sza´ros et al., 2007).
See also Tables S1–S4 and Figure S1.
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Intrinsic Disorder in Autoinhibitionthe family of receptor tyrosine kinases. However, circular
dichroism experiments indicate that the juxtamembrane region
of Kit is an independently folding domain (Chan et al., 2003).
Intrinsically disordered proteins have been shown to bury
more solvent accessible surface area (SASA) per residue at inter-
protein interfaces than structured proteins (Me´sza´ros et al.,
2007). We compared the per-residue buried SASA of the IMs
of the two groups with the SASA that is typically buried by intrin-
sically disordered and ordered proteins when they bind other
proteins (Figure 2D). Autoinhibited proteins in the idIM group
bury significantly more surface area per residue than do typical
ordered proteins (p value 3 3 1010; Wilcoxon test) but do not
differ significantly in interface area per residue when compared
to intrinsically disordered proteins (p value 0.8; Wilcoxon test).
Interestingly, proteins in the sIM group bury much less interface
area than do intrinsically disordered proteins (p value 2 3 104;
Wilcoxon test) but still more than ordered proteins (p value
4 3 104; Wilcoxon test). This increase in buried surface area
compared to ordered proteins is partially caused by borderline
cases, such as Kit and EPHB2, which bury 44 A˚2/res and
50 A˚2/res, respectively.
Overall, our findings suggest that a large fraction of autoinhi-
bited proteins contain intrinsically disordered IMs. It is important
to note that the number of autoinhibited proteins in the structural
data set (n = 46) as well as the one from the review by Pufall and
Graves (2002) (n = 39) is quite small, which asks for caution in the
interpretation of the results.
Regulation of Autoinhibition
Autoinhibition is a regulated process and various mechanisms of
relief and reinforcement have been identified (Figure 1) (Pufall
and Graves, 2002). In order to determine the frequency of occur-
rence of the different mechanims of regulation, we searched the
primary literature for corresponding evidence for the proteins in
the review and structural data sets (Tables S2 and S4). For about334 Structure 21, 332–341, March 5, 2013 ª2013 Elsevier Ltd All rights reservedtwo-thirds of the proteins of both sets,
at least one binding partner has been
identified that contributes either to reliefor reinforcement of autoinhibition (Figures S2A and S2B).
Phosporylation is the second-most frequent mechanism of
regulation; phosphorylation modulates autoinhibition in 36%
and 37% of the proteins in the two sets. Only about 10% of
the autoinhibited proteins are activated by proteolysis of the
IM. Interestingly, autoinhibition is regulated in a few proteins by
alternative mechanisms, such as disulfide bond formation or
mechanichal unfolding of the IM. Nevertheless, the analysis
confirms that partner binding, phosphorylation, and proteolysis
are the key players in the regulation of autoinhibition. It is clear
that Figure 1 oversimplifies the regulation of autoinhibition as
the different mechanisms of regulation can occur in combination
in the same protein. Indeed, in 22% of the autoinhibited proteins
from the structural data set, both phosphorylation and partner
binding have been shown to affect the equilibrium between the
active and inactive states.
Next, we investigated whether autoinhibition of proteins with
idIM or sIM is regulated differently (Figure S2C). No major differ-
ences exist between these two groups with respect to the
number of proteins in which partner binding and proteolysis
modulates autoinhibitory activity. However, phosphorylation
contributes to regulation in 47% of the autoinhibited proteins
with idIMs, whereas this is the case for only 27% of the proteins
with sIMs. Finally, we explored whether autoinhibition is more
often allosteric or steric in nature. Autoinhibition is steric for the
large majority of proteins with idIMs and sIMs (96% and 77%,
respectively; Figure S2D). These results affirm the important
role of partner binding and phophorylation in the regulation of
autoinhibition and reveal only small differences in the statistics
of the regulation of autoinhibited proteins with idIMs and sIMs.
Enrichment of Phosphorylation Sites in idMs
Essential to all autoinhibitory mechanisms is that the equilibrium
can be shifted between active and inhibited states, phosphoryla-
tion being the second most important player in this process, as
A B C
D E F
Figure 3. Examples of Autoinhibited Proteins with Known Structure
(A–F) FDs and IMs are shown in cyan and blue, respectively. The name or type of the domains in the FD and IM is provided, if available. The dominant mechanism
of regulation of autoinhibition is indicated as a symbol in the black squares. The same symbols are used as in Figure 1. Key residues that are important for
regulation are highlighted in magenta.
(A) Subtilisin BPN’. The protease is autoinhibited by a prodomain. A central event of activation is the proteolytic cleavage of the prodomain.
(B) FERM domain of moesin. The domain is inhibited by the C-terminal tail region of moesin. The tail region masks the binding site of the FERM domain.
Phosphorylation of a Thr residue is a key step in the activation of moesin. Phosphorylation is believed to promote unfolding of the helices in the tail domain and
permit binding of FERM to its partners.
(C) Calmodulin-dependent protein kinase I (CaMKI). CaMKI is autoinhibited by an intrinsically disordered segment that contains a calmodulin (CaM) binding
region. The IM interacts close to the ATP-binding site, which prevents ATP binding. Binding of CaM to the IM relieves autoinhibition.
(D) p47phox. Tandem SH3 domains of p47phox are autoinhibited by the pseudo-substate-like binding of a polybasic IM. Phosphorylation of multiple serines in the
IM relieve autoinhibition and enable p47phox to bind target sequences with its SH3 domains.
(E) c-Kit receptor tyrosine kinase. The juxtamembrane domain (IM) of c-Kit inserts into the cleft between the N- and C-terminal lobes of the kinase and sterically
blocks the conserved kinase motif (DFG) from adopting a productive conformation. Inhibition is relieved via phosphorylation of residues in the IM.
(F) Src tyrosine kinase. Phosporylation of a Tyr in the C-terminal tail of the kinase reinforces autoinhibition by promoting intramolecular interactions between the
tail and the SH2 domain. In addition, the linker connecting the SH2 domain to the kinase domain adopts a polyproline II conformation that is bound by the SH3
domain. Hence, multiple intramolecular interactions lock c-Src in an allosterically autoinhibited conformation. A key step in the relief of autoinhibition is the
dephosphorylation of the Tyr in the C-terminal tail.
Structure
Intrinsic Disorder in Autoinhibitionseen above. Our finding that phosphorylation more often
contributes to the regulation in autoinhibited proteins with idIMs
than in those with sIMsmay not be a surprise, given that proteins
with intrinsically disordered segments have previously been
shown to be more often phosphorylated than highly structured
ones (Gsponer et al., 2008). However, phosphorylation is so
ubiquitous and important in the regulation of autoinhibition that
such a difference is notable. As our literature search may have
missed instances in which phosphorylation plays a role in the
regulation of the autoinhibited proteins, and because experi-
mental evidence in some cases is not yet conclusive, we under-
took more systematic steps to identify phosphorylation sites.Structure 21,Using the PhosphoSitePlus database (Hornbeck et al., 2012),
which contains manually curated experimental data on phos-
phorylation sites (PS) in vertebrates, we found that 12 of 17 idIMs
(71%) and only 3 of 13 sIMs (23%) contain two or more PS
(p value 0.01; Fisher’s t test). An example of an autoinhibited
protein with multiple PS in the IM is shown in Figure 3D. On
average, every 15th residue in the idIMs is a phosphorylation
site compared to every 40th residue in sIMs (p value 0.03;
Wilcoxon test, Figure 4A).
In order to assess whether the PS are critical to the stability of
the interface between IM and FD, we determined how many of
them contribute more than 1 kcal/mol to the interaction, that is,332–341, March 5, 2013 ª2013 Elsevier Ltd All rights reserved 335
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A B C Figure 4. Comparison of idIMs and sIMs
(A) Box plot of the distribution of percentages of
residues that are phosphorylation sites in idIMs
(green) and sIMs (gray). *p < 0.05.
(B) The numbers of autoinhibited proteins ex-
hibiting (colored) or not exhibiting (white)
secondary structural changes upon activation for
both idIM and sIM proteins.
(C) The numbers of autoinhibited proteins con-
taining (colored) or not containing (white) a splice
isoform with altered idIM and sIM.
See also Figure S3.
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Intrinsic Disorder in Autoinhibitionare interaction hot spots. To do so, we carried out a computa-
tional alanine scan in which we mutated each PS to alanine
and determined the change in interaction energy with Rosetta
(Leaver-Fay et al., 2011) (see the Experimental Procedures). In
the three proteins with a structured IM and multiple PS, seven
of the nine sites are interaction hot spots. In contrast, only 5 of
the 71 PS located in the 12 idIMs are hot spots (p value 4 3
107; c2-test).
As the number of phosphorylation sites that could be analyzed
is rather small, the presented results have to be interpreted with
caution. Nevertheless, the analysis suggests that most phos-
phorylation sites in idIMs are not acting as interaction hot spots.
Some of these non-hot-spot PS may mediate interactions of the
IM with other proteins, thereby contributing to the regulation of
the shift between active and inactive states. The location of these
phosphorylation sites in a flexible, intrinsically disordered region
is likely to be advantageous for interactingwith phosphopeptide-
binding domains. In addition, a layered organization of the phos-
phorylation sites in the idIM, with some being more accessible
and less tightly interacting with the FD, may enable sequential
steps for activation that depend on kinase/phosphatase acces-
sibility (Yu et al., 2010).
Structural Changes in idIM Facilitate Activation
Another advantage of intrinsically disordered segments in
proteins over structured ones is that they can adopt different
secondary and tertiary structures and thereby enable interac-
tions with very diverse partners (Gsponer and Babu, 2009).
Autoinhibition is often relieved by binding of the IM to partner
proteins. Therefore, we analyzed how frequently changes
occurred in IMs with known structure upon activation. To do
so, we assembled structures of these IMs when bound to other
partners and/or present in the active state of the autoinhibited
protein. Among the 11 idIMs for which such structures were
available, eight exhibited a change in secondary structure. For
two additional idIMs, hydrogen exchange and chemical shift
data indicate changes in secondary structure upon activation.
Meanwhile, only one out of nine sIMs showed changes in
secondary structure upon activation (Figure 4B; p value 9 3
103; Fisher’s t test). Significant modifications of tertiary struc-
ture occur in none of the sIM but are observed in the idIMs of
WASP and PAK1 upon activation by GTPase Cdc42 (Kim
et al., 2000; Morreale et al., 2000).
In all idIMs that show secondary structural changes upon
activation of the autoinhibited protein, the changes include either
a coil-to-helix or a helix-to-coil transition. In the four cases of
helix-to-coil transition, one or several helices are present in the336 Structure 21, 332–341, March 5, 2013 ª2013 Elsevier Ltd All righautoinhibited state andmelt upon activation of the protein, which
concomitantly exposes phosphorylation sites. Representative
examples of this type of activation are the relief of autoinhibition
in Vav1 (Li et al., 2008) or Moesin (Figure 3B) (Jayaraman and
Nicholson, 2007). For Vav1, it has been shown that the melting
of the autoinhibitory helix is fast relative to the phosphorylation
and activation of the FD, and the activating phosphorylation is
proportional to the population of the state with a melted autoin-
hibitory helix (Li et al., 2008).
In the majority of cases, a coil-to-helix transition is observed
whereby the folding of a short helix is induced upon binding of
parts of the idIM to an activating partner protein. Hence, these
idIMs contain a short molecular recognition motif (MoRF) that
folds upon binding to an activating partner Mohan et al.
(2006). Calmodulin-dependent kinases (Clapperton et al.,
2002) represent good examples of this type of activation,
which is characterized by induced helix formation in parts of
the idIM upon binding to calmodulin (Figure 3C). Further exam-
ples are the Na+/H+ exchanger regulatory factor (NHERF)
(Bhattacharya et al., 2010) and the nuclear importer importin-a
(Catimel et al., 2001). The latter can bind proteins with a nuclear
localization signal (NLS) and imports them into the nucleus by
forming a heterodimer with importin-b (Figure S3). Importin-a
exists in an autoinhibited state in which an idIM prevents
binding to the NLS. Autoinhibition is relieved by binding of
the idIM to importin-b. The high-affinity binding to importin-b
(KD = 11 nM) is associated with the formation of a helix in
the idIM (Catimel et al., 2001). This example illustrates the
advantage that idIMs can provide by exposing short MoRFs
that fold upon binding and have evolved to bind specifically
to activating proteins.
Splicing Isoforms Are More Frequent in idIMs
Alternative splicing is known to affect the mRNA of a large frac-
tion of mammalian genes and contribute significantly to the
complexity in cell signaling and regulation in a time- and
tissue-specific manner (Lareau et al., 2004). However, small
errors in the splicing of the IM of autoinhibited proteins can
have devastating effects as it can lead to constitutive activation
of the protein (Chen et al., 2005). In the light of recent computa-
tional analyses that showed that alternative splicing often occurs
in intrinsically disordered regions (Romero et al., 2006; Buljan
et al., 2012), we wondered whether splicing isoforms are more
frequent for the intrinsically disordered IMs than for structured
ones. For this analysis, we pooled the autoinhibited proteins
with known structures together with those published in the
review on autoinhibition by Pufall and Graves (2002) in order tots reserved
Table 1. Interface Characteristics of Inhibitory Modules
Group idIM sIM
SignificanceSize Mean (SD) Mean (SD)
Total SASA (A˚2) 1,403 (±766) 1,446 (±552) NS
SASA/residue (A˚2) 37 (±9) (24 ± 7) p = 7 3 103
Interface residues 24 (±13) 22 (±15) NS
Interactions
Total hydrogen
bonds (HB)
9.5 (±7.6) 6.2 (±5.7) NS
HBs per 100 A˚2 0.84(±0.75) 0.42 (±0.31) p = 0.05
Main-chain HB 5.3 (±4.8) 2.7 (±3.9) p = 0.05
Side-chain HB 4.0 (±3.1) 3.5 (±3.0) NS
Salt bridges 1.8 (±1.6) 1.7 (±1.6) NS
Salt bridges per 100 A˚2 0.1 (±0.1) 0.1 (±0.1) NS
Interaction Hot Spots
Total number of
hot spots
8.0 (±4.0) 6.6 (±4.5) p = 0.01
Average DDG of hot
spots (kcal/mol)
2.0 (±0.5) 2.2 (±0.9) NS
Average DDG of non-
hot-spots (kcal/mol)
0.24 (±0.18) 0.26 (±0.09) NS
Hydrophobic hot spots 3.5 (±2.4) 1.5 (±1.5) p = 2 3 103
Aromatic hot spots 1.4 (±1.3) 2.3 (±2.0) NS
Charged hot spots 1.7 (±1.7) 1.4 (±1.0) NS
Polar hot spots 1.4 (±0.9) 1.4 (±1.0) NS
NS, not significant. See also Table S5 and Figure S4.
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Intrinsic Disorder in Autoinhibitionget a larger data set. Isoform data was retrieved from Ensembl
(Flicek et al., 2012). For the autoinhibited proteins with idIMs
and known isoforms, significantly more often an isoform was
foundwith altered sequence of the IM compared to autoinhibited
proteins with sIMs (p value 0.04; Fisher’s t test; Figure 4C). What
are the advantages of having different isoforms of the idIMs?
Removal or addition of MoRFs or short linear motifs in intrinsi-
cally disordered segments of proteins via alternative splicing
can modulate the set of potential interaction partners (Buljan
et al., 2012). In autoinhibited proteins, this mechanism could
be exploited to change activating partners. For instance, for
the p21-activated kinase PAK3, a paralog of PAK1 in our set,
an isoform with a 15-residue insertion in the idIM has been
reported, which is expressed in mouse brain (Rousseau et al.,
2003). This PAK3 isoform displays a high kinase activity and
the 15-residue insertion in the idIM impedes binding of the
canonical activators Rac and Cdc42. In addition, small changes
in sequence composition or length of the idIM can significantly
affect how much basal activity an autoinhibited protein has
(Buck et al., 2004). It has to be stressed that alternatively spliced
isoforms also occur in proteins with sIMs, but splicing within
a structured region is arguably subject to more constraints in
order to preserve functionality and prevent misfolding. Hence,
altering the composition of the idIM by alternative splicing is
likely to be an effective approach used in the fine-tuning of the
equilibrium between active and inactive states of autoinhibited
proteins as well as in the selection of activating partners in
a time- and tissue-specific way.Structure 21,Energetics of Equilibrium between Active and
Inactive States
Energetics of IM-FD Interfaces
All the mechanisms analyzed above serve to either fine-tune or
shift the balance between active and inactive states, that is,
they affect the thermodynamic stability of the IM-FD ‘‘complex’’.
This stability essentially depends on (1) the interaction energy
between FD and IM and (2) the structural changes of FD and
IM prior to the intramolecular interaction (Figure S4). With regard
to the first factor, we analyzed the characteristics of IM-FD inter-
faces (Table 1) as has been previously done for transient protein-
protein and peptide-protein interactions (Nooren and Thornton,
2003; Me´sza´ros et al., 2007; London et al., 2010). Similar to
various transient heterodimers, IMs bury a large SASA upon
interaction with the FD. However, on average they form only
about 0.6 hydrogen bonds and 0.1 salt bridges per 100 A˚2, which
is at the lower end of the spectrum of the number of hydrogen
bonds and salt bridges that are found in transient heteromeric
protein interfaces (see SI in London et al., 2010). This sparsity
in interface hydrogen bonds is most pronounced for sIMs.
They form significantly fewer interface hydrogen bonds per
100 A˚2 than do idIMs. As expected, idIM-FD interfaces show
the characteristics of interfaces in which one partner is disor-
dered in isolation. They bury more SASA per residue in the IM
(see also Figure 2D) than structured ones and hydrogen bonds
across the IM-FD interface are more often mediated by main-
chain atoms (Me´sza´ros et al., 2007).
The importance of hot-spot residues for protein-protein as
well as peptide-protein interactions has been reported previ-
ously (Rajamani et al., 2004; London et al., 2010). We assessed
the importance of such interaction hot spots for IM-FD interac-
tions by carrying out a computational alanine scan (see the
Experimental Procedures). Consistent with previous findings
for protein-protein and peptide-protein interfaces (Rajamani
et al., 2004; London et al., 2010), IMs have few amino acids in
their sequence (on average 8 of 24 and 7 of 22 in idIMs and
sIMs, respectively) that when mutated to alanine destabilize
the interface significantly more than the other interface residues
(on average, 2 kcal/mol in Rosetta energy units). Interestingly
idIMs have slightly more hot spots than sIMs (Table 1). This
difference is mainly due to the increased number of hydrophobic
hot spots in idIMs when compared to sIMs. However, in both
idIMs and sIMs, the top ranked hot-spot residues, that is, those
which have the largest DDG when mutated to alanine, are
aromatic or charged (Table S5). Overall, these analyses show
that interfaces formed by idIMs and sIMs are not very different
to other protein interfaces but seem to have a low number of
hydrogen bonds given their large interaction interfaces. This
may not surprise, as the high local effective concentration will
enable binding of IMs to FDs evenwithout the presence of a large
number of complementary interactions. High numbers of such
interactions may even not be desired as they could overstabilize
the inhibited state and thereby increase the barrier for relief of
autoinhibition.
IdIMs Can Have a Broad Spectrum of Disorder in Some
Families of Autoinhibited Proteins
The analysis of IM-FD interfaces alone provides only limited
insights into the energetics of binding because structural
changes in the IM and FD prior to or upon binding have to be332–341, March 5, 2013 ª2013 Elsevier Ltd All rights reserved 337
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Figure 5. Disorder Distribution and Se-
quence Conservation in the idIMs of Homol-
ogous Proteins
(A–C) Predicted levels of disorder for the FDs
(cyan) and IMs (dark blue) of homologous mem-
bers of the CaM/S100-dependent kinase (A), sub-
tilisin protease (B), and PAK1 kinase (C) families.
(D) Box plot of the distribution of sequence
entropy per position in FDs, IMs, and among the
IIRs of the idIM proteins. **p < 0.001.
See also Figure S5.
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Intrinsic Disorder in Autoinhibitionconsidered as well. Experimental work by Palmer and
colleagues recently revealed that the exposure of a Trp in the
inhibitory cSH3 domain of Crk-II upon interdomain interaction
with the FD of this protein partially compensates the favorable
IM-FD interactions and avoids overstabilization of the autoinhi-
bited state (Cho et al., 2011). IdIMs that fold upon binding to
the FD are likely to offset favorable IM-FD interactions signifi-
cantly because of the entropic penalty to be paid in this process.
Hence, modulating the degree of structure already present in the
idIM when not inhibiting the FD may be used as an additional
evolutionary ‘‘tool’’ to fine-tune the balance between active
and inactive states. If this is the case, homologs of autoinhibited
proteins with idIMs that are used in different signaling pathways
or organisms are likely to have various levels of disorder in the
unbound state of the IM.
In order to investigate this hypothesis, we predicted the
disorder for the members of different families of autoinhibited
proteins that have well-defined boundaries for the IMs. First,
we analyzed giant protein kinases, MLCKS, and calmodulin
(CaM)-dependent kinases that are activated when the idIM is
sequestered by CaM or S100 (Kobe et al., 1996). In the inhibited
state, helices fold upon binding of the idIM to the catalytic kinase
domain of these proteins. Sequence-based disorder predictions
for homologs of these kinases in different vertebrates reveal that
the IMs of these kinases have a very broad spectrum of disorder.
The IMs in some homologs have no predicted disorder, whereas
IMs in other members of the family are predicted to be 80%
disordered (Figure 5A). In contrast, the catalytic domains of all
these kinases are predicted to have minimal disorder, as can
be expected. A similar picture emerges when the autoinhibitory
prodomains of members of the subtilisin protease family are
analyzed (Figure 5B). These predictions are supported by exper-338 Structure 21, 332–341, March 5, 2013 ª2013 Elsevier Ltd All rights reservediments that have previously shown that
the prodomains of many subtilisins do
not fold by themselves, that is, when ex-
pressed without the protease domain
(Eder et al., 1993; Falzon et al., 2007).
However, in aqualysin I, a homolog of
subtilisin, the prodomain folds spontane-
ously and reversibly into a stable mono-
meric a-b conformation (Marie-Claire
et al., 2001). Interestingly, this prodomain
inhibits subtilisin activity 10-fold stronger
than the intrinsically disordered prodo-
main of subtilisin E. As mentioned before,
receptor tyrosine kinases (Hubbard,2004) that are inhibited by juxtamembrane domains represent
a borderline case for our classification of autoinhibited proteins
with structured or intrinsically disordered IMs. Consistent with
this view, some members of this family are predicted to have
more than 50% of their sequence disordered (Figure S5). It is
important to note that a broad spectrum of disorder is not found
for all protein families with idIMs. For instance, a very high level of
disorder was predicted for the idIM of all members of the PAK1
family of kinases (Figure 5C). Overall, these computational anal-
yses and experimental data reveal that, at least for some families
of autoinhibited proteins, broad levels of intrinsic disorder are
found in the IMs of different family members. This finding is
consistent with the idea that modulating the degree of structure
in the unbound IM could be exploited in some autoinhibited
protein families to contribute to the fine-tuning of the balance
between active and inhibited states.
Inhibitory Interface Residues in idIMs Are Conserved
The variations in predicted disorder for the idIMs seen before
reflect changes in the amino acid composition. These changes
can potentially affect any idIM residue. However, one might
expect interface residues to have less variation to minimize
changes to the interface. We compared the level of conservation
of residues in the FD with the conservation of idIM residues
within and outside the interface (Figure 5D). As expected, resi-
dues in the idIM that are not part of the interface are significantly
less conserved than residues in the FD (p value 1 3 1016;
Wilcoxon test). By contrast, IIRs display, on average, no signifi-
cant difference in their level of conservation when compared to
residues in the FD (p value 0.6 ; Wilcoxon test) but are signifi-
cantly more conserved than other residues in the idIM (p value
43 1012;Wilcoxon test). This result let us speculate that various
Structure
Intrinsic Disorder in Autoinhibitionlevels of disorder in unbound idIMs of different members of the
same family of autoinhibited proteins can be achieved without
affecting autoinhibition by, at least partial, conservation of the
residues at the FD-IM interface, whereas other residues in the
IM are more free to evolve.
Conclusions
Essential to the proper integration of autoinhibited proteins in
signaling cascades is (1) the fine-tuning of the equilibrium
between active and inactive states in order to reach the appro-
priate level of basal activity of the protein and (2) the availability
of specific mechanisms to shift the equilibrium and activate the
protein upon signal arrival. Our findings suggest that the special
properties of intrinsically disordered segments could be advan-
tageous for both aspects of autoinhibition. Multiple accessible
phosphorylation sites and structural variability are enriched in
idIMs. Both these features are likely to be used in many autoin-
hibited proteins in a combinatorial way to ensure highly specific
activation. As the folding upon binding of idIMs is associated
with an entropic penalty that can offset favorable IM-FD interac-
tions, modulating the intrinsic level of structure in the IM may be
used to contribute to the fine-tuning of the balance between
active and inactive states and thereby not only affect basal
activity of the FD but also the interaction likelihood of kinases/
phosphatases or other activating partners. The finding that levels
of disorder of IMs can vary throughout homologous members of
some autoinhibited protein families is consistent with this
hypothesis. In conjunction with alternative splicing, which we
found enriched in idIMs, changes in intrinsic disorder are likely
to alter in an organism- and tissue-specific way the dynamics
of the signaling process the autoinhibited protein is involved in.
Once more, we would like to stress that a limitation of this
work is the small number of proteins that could be analyzed.
Additional studies are required to confirm our findings in other
autoinhibited proteins and underline the importance of intrinsic
disorder in autoinhibition.
EXPERIMENTAL PROCEDURES
Assembly of Sets of Autoinhibited Proteins
A first set of autoinhibited proteins was taken from the review by Pufall and
Graves (2002). IM definitions for these proteins were taken from the original
papers, where the autoinhibition of these proteins was detected. This set of
proteins, their IM definitions, and calculated levels of disorder are given in
Table S1.
Proteins for which structural information about the mechanism of autoinhibi-
tion is available were located in two ways: by searching (1) the Protein Data
Bank (Berman et al., 2000) at http://www.pdb.org for structures matching
the key word ‘‘autoinhibition’’, and (2) the PubMed database (Wheeler et al.,
2006) at http://www.ncbi.nlm.nih.gov/pubmed for papers containing both
‘‘autoinhibition’’ and ‘‘structure’’ in their titles or abstracts (as of December
2011). Candidate proteins were required to have a structure containing at least
50% of the residues of the autoinhibitory module and the functional domain or
region it inhibits, as identified in literature citing the structure. All candidate
proteins in the set were test-aligned against each other with a Needleman-
Wunsch alignment as implemented in the EMBOSS package (Finn et al.,
2010) to test for redundancy in the set; pairs of proteins with more than 50%
sequence similarity were removed. The resulting ‘‘structural set’’ of proteins
is listed in Table S3. It is important to note that this list is likely to miss certain
autoinhibited proteins with known structure because not all autoinhibited
proteins are labeled as such in the databases. Nevertheless, this list should
at least provide a representative sample of autoinhibited proteins.Structure 21,Disorder Calculations
For the analysis of the levels of disorder associated with known autoinhibited
proteins, we used four different algorithms that predict intrinsic disorder based
on sequence information only. Predictions were made with the IUPred algo-
rithm (Doszta´nyi et al., 2005), the DISOPRED2 algorithm (Ward et al., 2004),
the VLXT predictor of the PONDR package (Li et al., 1999; Romero et al.,
2001), and the ESpritz algorithm (Walsh et al., 2012). All disorder predictions
presented in the main text were made with the DISOPRED2 algorithm (Ward
et al., 2004). However, the observed trends are independent of the predictor
used (see Figure S1).
As controls for the set taken from the review by Pufall andGraves (2002), two
additional sets of 900 subsequences each were constructed. The first control
set was sampled from the same autoinhibited proteins but from the non-IM
regions, and the second control set from randomly selected members of the
human proteome. The sequences were chosen to have the same length distri-
bution as the set of IMs, to account for any correlation between protein length
and level of predicted disorder. For the set of autoinhibited proteins with
known structure, the first control set was constructed from subsequences
randomly selected from regions of the same proteins not implicated in autoin-
hibition. The second control set was constructed from proteins randomly
sampled from the Protein Data Bank. Both comparison sets had the same
distribution of sequence lengths as the IMs of the structural set.
Classification of the Autoinhibited Proteins in the ‘‘Structural’’ Set
IMs were classified as intrinsically disordered when (1) experimental evidence
was available or (2) at least two algorithms predicted that more than 50% of
the residues in the IM were intrinsically disordered. Experimental evidence
for intrinsic disorder was collected from the literature. In the original papers,
the IMs were defined as intrinsically disordered based on data collected by
different techniques, including circular dichroism and nuclear magnetic reso-
nance spectroscopy, small-angle X-ray scattering, hydrogen exchange, and
proteolysis experiments. IMs were classified as structured when (1) they con-
tained a Pfam-annotated domain (see Table S3) or (2) not more than one algo-
rithm predicted more than 50% of the residues in the IM to be disordered.
Calculations of the Solvent Accessible Surface Area
The SASA was calculated using AREAIMOL from the CCP4 suite with a point
density of 25 A˚2 and the default probe radius of 1.4 A˚ (Lee and Richards,
1971). The buried SASA was calculated as the mean of the SASA buried
by the FD and IM. Reference complexes that contained only globular proteins
or in which one partner is intrinsically disordered were taken from a study by
Me´sza´ros et al. (2007).
Phosphorylation Sites
We identified phosphorylation sites in the IMs of vertebrate proteins in the
structural set by using the PhosphoSitePlus database (Hornbeck et al.,
2012). This database contains manually curated experimental data on phos-
phorylation sites in vertebrates.
Hot Spots Analysis
In order to identify interaction hot spots, a computational alanine scan was
carried out by using the Rosetta software (Leaver-Fay et al., 2011) as reported
by Kortemme and Baker (2002). Hot spots are defined as residues that upon
mutation to alanine are predicted to change the interaction energy by more
than 1 kcal/mol (in Rosetta energy units).
Analysis of Hydrogen Bonds and Salt Bridges
Hydrogen bonds (HB) were calculated using the HBplus software with default
parameters (McDonald and Thornton, 1994). Salt bridges were defined as
opposing charges across the FD-IM interface with a cutoff of 4 A˚.
Structural Changes
To identify structural changes upon activation, the Protein Data Bank was
searched for alternative structures of the proteins in the ‘‘structural’’ set. In
these alternative structures, the IMs were either not bound to the FD, that is,
the protein is in its active form, or the IMs are bound to another partner protein.
Secondary structural changes were identified by comparing the DSSP charts
of the IMs in the autoinhibited and alternative structures. Only changes in the332–341, March 5, 2013 ª2013 Elsevier Ltd All rights reserved 339
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utive residues were counted.
Splicing Isoforms
Splicing isoforms were retrieved from the Ensembl database (Flicek et al.,
2012). Splicing was considered to affect the IM if an isoform exists that alters
the sequence of the IM (insertion or deletion) but has no effect on the sequence
of the FD.
Calculation of Intrinsic Disorder and Sequence Conservation in
Protein Families
To evaluate the relative degree of sequence conservation for residues in the IM
and FD, homologs were identified in the InParanoid7 database (Ostlund et al.,
2010) for each vertebrate protein in the structure set. Homologs with an
E-value %1095 were then aligned using the MUSCLE algorithm (Edgar,
2004), and the Shannon entropy (Chen et al., 2006) for each sequence position
was calculated, discarding sequence positions containingmore than two gaps
in the entire alignment. The Shannon entropy is defined as
SðXÞ= 
X20
i
pi ln

pi

; (1)
where S is the entropy value, X is the alignment column number, and pi is the
probability for the ith letter of the amino acid alphabet. For subtilisin, family
members were taken from Siezen and Leunissen (1997). Inhibitory interface
residues (IIRs) were defined as those IM residues that had at least one atom
that was within 6 A˚ of any atom of the FD. Prediction for the disorder in families
of autoinhibited proteins were made with DISOPRED2.
Statistical Testing
All statistical analyses were done with the R package (Ihaka and Gentleman,
1996).
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